Annual Total Expenses
$444.68 M
-$66.21 M-12.96%
December 31, 2024
Summary
- As of March 10, 2025, PACB annual total expenses is $444.68 million, with the most recent change of -$66.21 million (-12.96%) on December 31, 2024.
- During the last 3 years, PACB annual total expenses has risen by +$136.00 million (+44.06%).
- PACB annual total expenses is now -12.96% below its all-time high of $510.89 million, reached on December 31, 2023.
Performance
PACB Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$102.90 M
+$28.00 K+0.03%
December 31, 2024
Summary
- As of March 10, 2025, PACB quarterly total expenses is $102.90 million, with the most recent change of +$28.00 thousand (+0.03%) on December 31, 2024.
- Over the past year, PACB quarterly total expenses has increased by +$28.00 thousand (+0.03%).
- PACB quarterly total expenses is now -28.91% below its all-time high of $144.74 million, reached on December 31, 2023.
Performance
PACB Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
PACB Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.0% | +0.0% |
| 3 y3 years | +44.1% | +0.0% |
| 5 y5 years | +132.3% | +0.0% |
PACB Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.0% | +44.1% | -28.9% | +3.8% |
| 5 y | 5-year | -13.0% | +142.6% | -28.9% | +153.4% |
| alltime | all time | -13.0% | +1640.2% | -28.9% | +318.9% |
Pacific Biosciences Of California Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $444.68 M(-13.0%) | $102.90 M(+0.0%) |
| Sep 2024 | - | $102.87 M(-13.3%) |
| Jun 2024 | - | $118.66 M(-1.3%) |
| Mar 2024 | - | $120.24 M(-16.9%) |
| Dec 2023 | $510.89 M(+18.0%) | $144.74 M(+11.8%) |
| Sep 2023 | - | $129.47 M(+9.0%) |
| Jun 2023 | - | $118.77 M(+0.7%) |
| Mar 2023 | - | $117.90 M(+7.3%) |
| Dec 2022 | $433.12 M(+40.3%) | $109.84 M(+7.0%) |
| Sep 2022 | - | $102.65 M(-5.7%) |
| Jun 2022 | - | $108.87 M(-2.6%) |
| Mar 2022 | - | $111.76 M(+12.7%) |
| Dec 2021 | $308.68 M(+68.4%) | $99.15 M(+26.1%) |
| Sep 2021 | - | $78.64 M(+15.3%) |
| Jun 2021 | - | $68.18 M(+8.7%) |
| Mar 2021 | - | $62.71 M(+22.7%) |
| Dec 2020 | $183.28 M(-4.3%) | $51.11 M(+18.2%) |
| Sep 2020 | - | $43.26 M(+6.5%) |
| Jun 2020 | - | $40.60 M(-16.0%) |
| Mar 2020 | - | $48.31 M(+5.4%) |
| Dec 2019 | $191.44 M(+6.6%) | $45.85 M(-8.4%) |
| Sep 2019 | - | $50.03 M(+2.1%) |
| Jun 2019 | - | $49.00 M(+5.2%) |
| Mar 2019 | - | $46.56 M(-7.2%) |
| Dec 2018 | $179.61 M(-2.0%) | $50.15 M(+17.1%) |
| Sep 2018 | - | $42.83 M(-1.1%) |
| Jun 2018 | - | $43.32 M(+0.0%) |
| Mar 2018 | - | $43.31 M(-4.7%) |
| Dec 2017 | $183.25 M(+13.1%) | $45.46 M(+0.8%) |
| Sep 2017 | - | $45.11 M(+1.5%) |
| Jun 2017 | - | $44.46 M(-7.8%) |
| Mar 2017 | - | $48.21 M(+10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $161.96 M(+11.7%) | $43.60 M(+4.2%) |
| Sep 2016 | - | $41.85 M(+7.8%) |
| Jun 2016 | - | $38.82 M(+3.0%) |
| Mar 2016 | - | $37.69 M(+0.9%) |
| Dec 2015 | $144.96 M(+17.4%) | $37.34 M(+8.7%) |
| Sep 2015 | - | $34.35 M(-5.4%) |
| Jun 2015 | - | $36.30 M(-1.8%) |
| Mar 2015 | - | $36.97 M(+6.3%) |
| Dec 2014 | $123.45 M(+16.8%) | $34.80 M(+19.8%) |
| Sep 2014 | - | $29.04 M(-2.3%) |
| Jun 2014 | - | $29.73 M(-0.5%) |
| Mar 2014 | - | $29.89 M(+14.3%) |
| Dec 2013 | $105.72 M(-12.1%) | $26.14 M(-4.5%) |
| Sep 2013 | - | $27.36 M(+5.0%) |
| Jun 2013 | - | $26.05 M(-0.5%) |
| Mar 2013 | - | $26.18 M(-5.0%) |
| Dec 2012 | $120.32 M(-16.2%) | $27.57 M(+8.7%) |
| Sep 2012 | - | $25.36 M(-15.0%) |
| Jun 2012 | - | $29.85 M(-20.5%) |
| Mar 2012 | - | $37.55 M(+6.9%) |
| Dec 2011 | $143.62 M(+1.2%) | $35.13 M(-12.1%) |
| Sep 2011 | - | $39.96 M(+20.0%) |
| Jun 2011 | - | $33.29 M(-5.5%) |
| Mar 2011 | - | $35.24 M(-4.4%) |
| Dec 2010 | $141.91 M(+60.9%) | $36.87 M(-9.9%) |
| Sep 2010 | - | $40.92 M(+22.9%) |
| Jun 2010 | - | $33.30 M(+8.1%) |
| Mar 2010 | - | $30.82 M(+9.3%) |
| Dec 2009 | $88.20 M(+93.0%) | $28.21 M(+14.8%) |
| Sep 2009 | - | $24.57 M |
| Dec 2008 | $45.71 M(+78.9%) | - |
| Dec 2007 | $25.55 M | - |
FAQ
- What is Pacific Biosciences of California annual total expenses?
- What is the all time high annual total expenses for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual total expenses year-on-year change?
- What is Pacific Biosciences of California quarterly total expenses?
- What is the all time high quarterly total expenses for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly total expenses year-on-year change?
What is Pacific Biosciences of California annual total expenses?
The current annual total expenses of PACB is $444.68 M
What is the all time high annual total expenses for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual total expenses is $510.89 M
What is Pacific Biosciences of California annual total expenses year-on-year change?
Over the past year, PACB annual total expenses has changed by -$66.21 M (-12.96%)
What is Pacific Biosciences of California quarterly total expenses?
The current quarterly total expenses of PACB is $102.90 M
What is the all time high quarterly total expenses for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly total expenses is $144.74 M
What is Pacific Biosciences of California quarterly total expenses year-on-year change?
Over the past year, PACB quarterly total expenses has changed by +$28.00 K (+0.03%)